Prelude Capital Management, LLC Global Blood Therapeutics, Inc. Call Options Transaction History

Prelude Capital Management, LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2019 Nov 14, 2019	BUY	$45.35 - $57.91 $4,535 - $5,791	100 New	100 $5,000
Q4 2018 Feb 14, 2019	SELL	$31.54 - $46.67 $126,160 - $186,680	-4,000 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$38.0 - $51.1 $133,000 - $178,850	3,500 Added 700.0%	4,000 $152,000
Q2 2018 Aug 14, 2018	SELL	$38.7 - $50.15 $77,400 - $100,300	-2,000 Reduced 80.0%	500 $23,000
Q4 2017 Feb 14, 2018	BUY	$29.7 - $45.7 $74,250 - $114,250	2,500	2,500 $98,000

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Prelude Capital Management, LLC with notifications on news.